Trump's New Drug Pricing Plan Isn't "The Best Deal" For Patients


By Kenneth E. Thorpe

President Trump will soon unveil a new plan to reduce drug prices.

The proposal would indeed slash Americans' pharmacy bills -- at least temporarily. But those savings would come at the expense of patients' access to cutting-edge drugs. The reform would also jeopardize future medical breakthroughs.

The administration's proposal would restructure Medicare Part B, which covers advanced, physician-administered medicines that treat serious chronic diseases like cancer and multiple sclerosis. On average, Part B drugs cost 80 percent more in the United States than in other developed countries.

Why do Americans pay more for the exact same medicines?

Simple -- the United States doesn't impose price controls on pharmaceuticals; other nations do. Many foreign regulatory agencies won't even make medicines available to patients unless manufacturers offer enormous discounts.

As a result, patients in those nations have fewer treatment options. Consider cancer therapies. Ninety-five percent of all oncology medicines approved anywhere in the world between 2011 and 2018 were available in the United States. By contrast, patients in the United Kingdom and France had access to only 74 percent and 65 percent of those treatments, respectively.

Inexplicably, the Trump administration wants to copy Europe's anti-patient policies.

Under the administration's proposal, Medicare would reimburse doctors based on an "international pricing index" -- essentially an average of the prices paid in other countries, including Canada, France, and the United Kingdom.

Indexing Part B reimbursements to these countries' prices would effectively import their access restrictions too. It'd deprive the sickest, most vulnerable Americans of their medicines.

The proposal would also discourage medical innovation.

Drug development is a challenging, expensive endeavor. It costs almost $3 billion, on average, to bring just one new drug to patients. And nearly 90 percent of all medicines that enter clinical trials ultimately fail to win FDA approval.

But if the United States adopts price controls, companies won't pursue as many research projects. The meager potential returns wouldn't justify the considerable risks.

A slowdown in medical innovation would jeopardize U.S. health gains. In the past three decades, cancer death rates have fallen 27 percent. Roughly three-quarters of those survival gains are attributable to new medicines.

By limiting patients' access to existing drugs and discouraging the development of future ones, the proposal would make it harder for Americans to manage their conditions and avoid costly complications. According to a study by my organization, the Partnership to Fight Chronic Disease, new medicines could avoid $6 trillion in healthcare costs and prevent 16 million deaths by 2030.

The administration's proposal condemns Americans to the same life-threatening access restrictions that patients in other countries endure. It's a lousy deal.

Kenneth E. Thorpe is a professor of health policy at Emory University and chairman of the Partnership to Fight Chronic Disease.

More Resources


01/10/2025
Carter Funeral Brings Rare, Needed Vision of Peace


more info


01/10/2025
Three More Biden Deceptions
The president can believe what he wants to believe, and at this point, there appears to be no convincing him otherwise.

more info


01/10/2025
A Nation Suffers Whiplash Between Biden and Trump
On any other day this might seem strange

more info


01/10/2025
Biden Admin Told Us To Censor True Info


more info


01/10/2025
Facebook Admits Error--'Fact Checkers' Still Complicit
Mark Zuckerberg seems to want to reverse Facebook's censorship efforts, but those publications that participated in the program are complicit.

more info


01/10/2025
In Defense of DEI
DEI refers to three simple but important words: diversity, equity and inclusion. These three values are indispensable

more info


01/10/2025
Woke Religion Burned People's Homes to the Ground
The wildfire devastation of Los Angeles occurred largely as a result of people in power adhering blindly and madly to a very bad religion.

more info


01/10/2025
LA's Poor Communication Should Have Residents Fuming


more info


01/10/2025
Republican Party's New Ground Game


more info


01/10/2025
Opening the DNC's Black Box
Why we're publishing a previously undisclosed list of all 448 members of the Democratic National Committee

more info


01/10/2025
The Most Under-Reported Story About Biden
What was the most under-reported news story during the Biden presidency? In the last week or so, there has been a sudden burst of recognition of the extent to which Democrats and the media worked together to cover up Biden's progressing cognitive decline. One media figure after another has com

more info


01/10/2025
Biden Is No Carter
In terms of character the 46th president doesn't come close to matching the 39th.

more info


01/10/2025
Biden Says He Could've Beaten Trump. That's Delusional
Not only is Biden overestimating his political skills, he's also ungraciously insulting his vice president.

more info


01/10/2025
Dresden in Los Angeles and Our Confederacy of Dunces
LA is burning. And the derelict people responsible are worried that they are found out as charlatans and empty suits.

more info


01/10/2025
The L.A. Apocalypse Was Entirely Predictable
Today on TAP: The hills above my hometown regularly catch fire, and developers regularly build there nonetheless.

more info



Custom Search

More Politics Articles:

Related Articles

Trump's Socialist Attack on Americans' Health and Medical INnovations Must Be Stopped


Imagine if Barack Obama signed an executive order implementing socialist price controls on prescription drugs. And suppose that decision limited the drugs available to patients, dried up funding for innovative new treatments and resulted in the unnecessary deaths of thousands of Americans a year.

Biden Won't Win Votes by Threatening Swing State Jobs


It sometimes seems as if former Vice President Biden is hell bent on losing this November.

New Drug Pricing Executive Order Burdens Patients


President Trump just signed an executive order designed to reduce drug prices. Dubbed a "Most Favored Nations" policy, the order pegs Medicare payments for medicines to the prices paid by foreign governments.

Enjoy Your Usual Life, But Vote


Occasionally we all feel like we are living in a rut. Our days and weeks are filled with the same activities and schedules. We mow grass, rake leaves, clean the house, sweep out the garage and do the same jobs. We go to the same grocery store on a certain day, wash our car at the same place and see the same people along the way. We go to the same place of worship, and read the same daily or weekly newspaper. Our lives are made up of routines, schedules and the usual.

The Sun is Shining


The Sun is shining today and will rise tomorrow. For more years than we know the Sun has followed this same pattern.

Giving Thanks to Society’s Economic Benefactors


With all the attention commanded by the presidential campaign, election, and aftermath, plus the ongoing COVID-19 story, many other issues have faded into the background. Though escaping the headlines, some of these other issues will be with us for a long time, and contributions to the public discussion of such issues will often have a long-term impact.

Importing Drugs Endangers Lives


On most issues, Democrats and Republicans remain deeply divided. But there's one policy that unites both -- prescription drug importation.

On the Impeachment and Conviction of President Trump


The House of Representatives, with the sole responsibility of impeachment, has passed a single Article of Impeachment charging President Donald Trump with committing a high crime, namely that he “made statements that encouraged—and foreseeably resulted in—imminent lawless action at the Capitol.” In short, his rally speech, it is claimed, amounted to “incitement to engage in the insurrection.”

Death of a Defector: Ion Mihai Pacepa, RIP


On February 14, 2021, the world quietly lost one of the most intriguing, enduring figures of the Cold War. He was Lt. Gen. Ion Mihai Pacepa, the highest-ranking Soviet Bloc official ever to defect to the United States.

Stop Businesses From Exploiting This Health Program for the Poor


Over the decades, Congress has created a number of programs intended to help the poor, the sick, the downtrodden. As a result, certain businesses and industries find ways to exploit these efforts and profit in ways lawmakers never foresaw or intended.

Preventing the Next Public Health Crisis Can Define Biden's Legacy


The Biden administration's plan to defeat the coronavirus is underway -- and notably includes intentions to "build better preparedness for future threats." This detailed guidance could not have come at a better time. While we are making progress against the current pandemic, we remain in the midst of a worsening health crisis posed by antibiotic resistance.

For Seniors' Sake, Protect the Innovation that Brought Us Covid Vaccines


The breakneck pace of Covid-19 vaccine development will go down in history books as one of the great triumphs of modern medicine.

Raise the Corporate Tax Rate? Economic Obtuseness in High Places


Having proposed trillions of dollars of additional federal spending, President Joe Biden and allies have launched a belated and somewhat desperate search for additional tax revenues. The economic reality is that there simply isn’t enough wealth available in the private sector to fund the explosion in government spending. The danger is that changes in the tax code may do more damage than good.

America's Goose that Lays the Golden Eggs


America's research and development institutions have long been the envy of our competitors, flourishing at the top of global rankings. But our state-of-the-art innovation capabilities — responsible for bringing COVID-19 vaccines and countless other breakthroughs to market — haven't flourished here by happenstance. They have been nurtured over decades of smart policies, and those policies are now at risk.

A Public Option Will Destroy Private Insurance


Congress is trying to chart a path forward on health reform. Several congressional Democrats just announced plans to draft a bill that would create a public health insurance option.